WallStSmart

Copart Inc (CPRT)vsLichen China Limited Class A Ordinary Shares (LICN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Copart Inc generates 18820% more annual revenue ($4.64B vs $24.52M). CPRT leads profitability with a 33.5% profit margin vs -89.6%. CPRT earns a higher WallStSmart Score of 57/100 (C).

CPRT

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 9.0Value: 6.0Quality: 8.5
Piotroski: 3/9Altman Z: 9.05

LICN

Avoid

26

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 9.00
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPRTUndervalued (+77.0%)

Margin of Safety

+77.0%

Fair Value

$172.07

Current Price

$30.96

$141.11 discount

UndervaluedFair: $172.07Overvalued

Intrinsic value data unavailable for LICN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPRT4 strengths · Avg: 10.0/10
Profit MarginProfitability
33.5%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
37.5%10/10

Strong operational efficiency at 37.5%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0510/10

Safe zone — low bankruptcy risk

LICN3 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

Areas to Watch

CPRT4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

EPS GrowthGrowth
2.3%4/10

2.3% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.692/10

Expensive relative to growth rate

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$29.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-56.1%2/10

Revenue declined 56.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CPRT

The strongest argument for CPRT centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 33.5% and operating margin at 37.5%.

Bull Case : LICN

The strongest argument for LICN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : CPRT

The primary concerns for CPRT are Revenue Growth, EPS Growth, Piotroski F-Score.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

CPRT profiles as a value stock while LICN is a turnaround play — different risk/reward profiles.

CPRT carries more volatility with a beta of 1.00 — expect wider price swings.

CPRT is growing revenue faster at 2.1% — sustainability is the question.

CPRT generates stronger free cash flow (503M), providing more financial flexibility.

Bottom Line

CPRT scores higher overall (57/100 vs 26/100), backed by strong 33.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Copart Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Copart, Inc. or simply Copart is a global provider of online vehicle auction and remarketing services to automotive resellers such as insurance, rental car, fleet and finance companies in 11 countries: the US, Canada, the UK, Germany, Ireland, Brazil, Spain, Dubai, Bahrain, Oman and Finland.

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

Want to dig deeper into these stocks?